Author reply to Letter to the Editor regarding ‘Exposures to Attention Deficit Hyperactivity Disorder medications reported to the New South Wales Poisons Information Centre (2014–2023): A retrospective study’

Bradlow RC Armstrong F Ogden E (2025) Adult Attention Deficit Hyperactivity Disorder in Australia: How its current commercial model for diagnosis and treatment is encouraging misdiagnosis. Medical Journal of Australia 223: 384–386.

Cairns R Buckley N (2023) Semaglutide exposures reported to the NSW Poisons Information Centre: Effects of social media marketing and supply chain disruptions. Internal Medicine Journal 53: 654–655.

Cairns R Allaf S Buckley NA (2025) Cannabis poisonings in Australia following the legalisation of medicinal cannabis, 2014–24: Analysis of NSW Poisons Information Centre data. Medical Journal of Australia 222: 155–157.

Thomson A Cairns RFJ Magotra H , et al. (2025) Exposures to attention deficient hyperactivity disorder medications reported to the New South Wales Poisons Information Centre (2014–2023): A retrospective study. Australian & New Zealand Journal of Psychiatry. Epub ahead of print 10 November. DOI: 10.1177/00048674251384053.